Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T15:41:17.236Z.
Calculation as of: 2026-10-06T15:41:17.236Z.
Quote observation: 2026-10-06T15:36:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1e75b902c2fc2180dd85d0e717aea95d739fa4c46657779fc742098741b775f2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Creative Medical Technology Holdings, Inc.
Market Cap
$2.33M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.55M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.58M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | $2.33M | N/A | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.33M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.33M | N/A | N/A | N/A | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.48M | N/A | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.52M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | N/A | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.58M | N/A | N/A | N/A | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.64M | N/A | 3804.98 | 3804.98 | 3804.98 |
| Autonomix Medical, Inc. (AMIX)vs › | $1.94M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
